Showing 13–24 of 475 results

  • Hepatolenticular degeneration

    D-penicillamine

    【Product name】Calcium edetate injection

    [English common name]D-Penicillamine

    [Chinese common name]D-penicillamine

    [English name]3-Mercapto-D-valine

    [Chinese other name]3-mercapto-D-proline

    [Indications] for the treatment of Wilson's disease, cystineuria and severe.

    [Usage and Dosage] Wilson's Disease - The optimal dose can be determined by measuring the measurement of urinary copper excretion and free copper in serum. Urine must be collected in copper-free glassware and copper should be quantified immediately before and after treatment with CUPRIMINE.
    Determination of 24-hour urinary copper excretion during the first week of treatment with penicillamine was the most valuable. In the absence of any drug response, a dose between 0.75 and 1.5 g results in over 2 mg of copperuria for the first 24 hours should last for about 3 months, at which time the most reliable method of monitoring maintenance therapy is to determine the serum. Free copper. This is equal to the difference between the total copper and ceruloplasmin-copper quantitatively determined. Well-treated patients usually contain less than 10 mcg of free copper/dL serum. A dose of more than 2 grams per day is rarely required. If the patient is unable to receive CUPRIMINE treatment, the replacement therapy is trientine hydrochloride.
    The usual dose of CUPRIMINE for the treatment of cystineuria is 2 g/day for adults, ranging from 1 to 4 g/day. For pediatric patients, the dose can be based on 30 mg / kg / day. The total daily amount should be divided into four doses. If four equal doses are not feasible, give a larger percentage before going to bed. If the adverse reaction requires a dose reduction, it is important to maintain the bedtime dose.
    Starting doses of 250 mg/day and gradually increasing to the required amount can more closely control the effects of the drug and may help reduce the incidence of adverse reactions.

    [Storage] Keep the container closed.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • other

    IMMU-132

    【Product name】

    [English common name] IMMU-132

    [Chinese common name]

    [English name]

    [Chinese other name]

    [indications]

    【Dosage】

    [Storage]

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Mitochondrial myopathy with hyperlactosis and stroke-like episodes (MELAS syndrome)

    L-arginine

    【Product name】Argi-U

    [English common name]L-Arginine

    [Chinese common name]L-arginine

    [English name](S)-2-Amino-5-guanidinopentanoic acid, L-protein amino acid

    [Chinese other name]2-amino-5-mercaptovaleric acid, L-protein amino acid

    [Indications] For the adjuvant treatment of diseases such as hepatic encephalopathy.

    [Usage and dosage] Oral. 3 to 6 tablets at a time, 3 times a day.

    [Storage] Sealed and stored in a dry place.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Multiple myeloma

    Marizomib

    【Product name】

    [English common name]Marizomib

    [Chinese common name]

    [English name]NPI-0052, NPI0052, NPI-0052, UNII-703P9YDP7F

    [Chinese other name]

    [indications]

    【Dosage】

    [Storage]

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Cushing's disease

    Metyrapone / 美替拉酮

    中文名称:美替拉酮
    英文名称:Metyrapone
    适  应  症:用于库欣综合症的治疗。
    品  牌  商:诺华/HRA
    生  产  厂:诺华/HRA
    产        地:法国
    规        格:250mg*50s

    适  应  症:美替拉酮一般用于治疗库欣综合症。可用于鉴别由垂体而引起的肾上腺皮质功能不全。

    用法用量:每次750mg,每4小时服1次,共6次。儿童15mg/kg。本品也可用于库欣综合征的治疗。每次0.2g,1日2次。可根据病情况调整用量到1次1g,1日4次。常用其胶囊剂,每胶囊250mg。口服,500~700mg/次,一次/6h,服1~2d。

  • 慢性心衰

    Nebivolol / 奈必洛尔片

    【商品名】Bystolic

    【英文通用名】Nebivolol

    【中文通用名】奈必洛尔

    [English name]

    【适应症】可以防止心跳变得太快并调节心率。它还可以扩张血管,这也有助于降低血压。该药物还用于治疗 70 岁及以上患者的轻度和中度慢性心力衰竭(心力衰竭)。

    【用法用量】始终完全按照医生告诉您的方式服药。如果您不确定,请咨询您的医生。
    治疗高血压(高血压)
    通常的剂量是每天 1 片。如果可能,应在一天的同一时间服用该剂量。
    老年患者和肾病患者通常每天服用 1/2(半片)片剂。
    治疗 1 至 2 周后,降血压效果变得明显。有时,仅在 4 周后才能达到最佳效果。
    治疗慢性心力衰竭(心力衰竭)
    一位经验丰富的医生将开始并密切监测您的治疗。
    您的医生将以每天 1/4(四分之一)片开始您的治疗。1 – 2 周后,每日剂量可增加至 1/2(半片),然后根据需要增至 1 片,然后根据需要增至 2 片,直至达到适合您的剂量。您的医生会在每一步为您开出正确的剂量,您应该仔细遵循他/她的指示。
    最大推荐剂量为每天 2 片(10 毫克)。
    在治疗开始时和每次增加剂量时,必须由有经验的医生仔细监测 2 小时。

    【Tips】Part of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctor's face diagnosis. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Pancreatic cancer

    Necuparanib

    【Product name】

    [English common name] Necuparanib

    [Chinese common name]

    [English name]

    [Chinese other name]

    [indications]

    【Dosage】

    [Storage]

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Spinal muscular atrophy

    Nusinersen

    【Product name】SPINRAZA

    [English common name]Nusinersen

    [Chinese common name]

    [English name]

    [Chinese other name]

    [indications]Spinal muscle atrophy.

    [Usage and Dosage] Infant spinal muscular atrophy is usually administered as a dose of Nuccinellsen in the table below. They were administered 2 weeks, 4 weeks and 9 weeks after the first administration, and administered at intervals of 4 months thereafter. In either case, intrathecal administration should be carried out within 1 to 3 minutes. Spinal muscular atrophy other than infant type is usually administered once as a dose in the table below as Nuccinellsen. Administration should be carried out 4 weeks and 12 weeks after the first administration, and thereafter at intervals of 6 months. In either case, intrathecal administration should be carried out within 1 to 3 minutes.

    [Storage] Store in the refrigerator (2 ° C – 8 ° C). Do not freeze. Place the vial in an outer carton to protect it from light.
    If not refrigerated, Spinraza can be stored in its original carton, protected from light at 30 ° C or below, for up to 14 days.
    Prior to administration, if necessary, the unopened Spinraza vial can be removed and returned to the refrigerator. If removed from the original carton, the total cooling time should not exceed 30 hours at temperatures not exceeding 25 °C.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Multiple sclerosis

    Ocrelizumab

    [product name] ocreves

    [English common name] ocrelizumab

    [Chinese common name]

    [English name]

    [Chinese other name]

    [Indications] Ocrevus is a treatmentMultiple sclerosisThe drug – Multiple Sclerosis is a neurological inflammatory disease that can cause symptoms such as weakness, difficulty walking and vision problems.
    Ocrevus is used in two groups of patients: adults with relapsing multiple sclerosis (RMS) who have a sudden onset (relapse) and then have a mild or asymptomatic period; with primary progressive multiple sclerosis (PPMS) Adults, as time goes on, the symptoms will gradually deteriorate.
    Ocrevus contains the active substance ocrelizumab.

    [Usage and Dosage] Ofcrevus enters the vein as an infusion (drop). The first two infusions were separated for two weeks and then infused every six months. Other medications (corticosteroids and antihistamines) are given to patients prior to each infusion to help prevent potentially dangerous reactions. If a reaction occurs during the infusion, a slower response can be stopped or given. Patients should be monitored during the infusion process and monitored at least one hour thereafter, and facilities that manage severe reactions should be readily available.

    [Storage]

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Lysosomal acid lipase deficiency

    Sebelipase alfa

    【Product name】Kanuma

    [English common name]Sebelipase Alfa

    [Chinese common name]

    [English name]Se be LYE pase AL fa

    [Chinese other name]

    [indications]KANUMATM is a specific hydrolyzed lysosomal cholesterol ester and triglyceride suitable for useLysosomal acid lipase (LAL) deficiencyDiagnose the treatment of the patient.

    【Dosage】The patient presented a rapid progression of LAL deficiency in the first 6 months of life: the recommended starting dose was 1 mg/kg as an intravenous infusion once a week. For patients who did not achieve optimal clinical response, increase to 3 mg/kg once a week.
    LAL-deficient children and adult patients: The recommended dose is 1 mg/kg as an intravenous infusion once every other week.

    [Storage]Store Kanuma in the original carton at a refrigerated temperature of 2 ° C to 8 ° C (36 ° F to 46 ° F) to prevent light exposure.Do not shake or freeze the vial.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Non-myeloid malignancy

    TBO-cell colony stimulating factor

    【Product name】Granix

    [English common name]Tbo-filgrastim

    [Chinese common name]TBO-Fogstone

    [English name]

    [Chinese other name]

    [indications]
    Recombinant human granulocyte colony-stimulating factor injection:
    1. Cancer chemotherapy and other reasons lead toNeutropeniaCancer patients use myelosuppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the granulocyte The duration of the deficiency accelerates the recovery of granulocyte counts, thereby reducing the risk of fever associated with infection.
    2. Promote an increase in the number of neutrophils after bone marrow transplantation.
    3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital, idiopathic neutropenia, myelodysplastic syndrome with neutral Agranulocytopenia, periodic neutropenia.
    TBO-granulocyte colony-stimulating factor pre-filled syringe: GRANIX (TBO-granulocyte colony-stimulating factor) is a clinically significant anti-myeloablative disease with the incidence of myelosuppression with febrile neutropenia The duration of severe neutropenia in cancer drugs is indicative of leukocyte growth factor.

    【Dosage】
    Recombinant human granulocyte colony-stimulating factor injection: The product is administered subcutaneously or intravenously 24 to 48 hours after the end of administration of the chemotherapy drug, once a day. The dosage and time of administration of this product should be determined according to the intensity of chemotherapy and the degree of neutrophil decline. For patients with greater chemotherapy intensity or decreased granulocyte count, it is more suitable to continue to take the drug for more than 7 days at a dose of 2.5 μg/kg body weight/day until the neutrophil is restored to 5000/mm3; if the dose of chemotherapy drug is used Lower, estimated to cause less severe myelosuppression, consider using a lower dose to prevent neutropenia, 1.25μg / kg body weight / day dose to the neutrophil number is stable in a safe range, Patients with significantly reduced neutrophils after chemotherapy (neutrophil count <1000/mm3).
    TBO-granulocyte colony stimulating factor prefilled syringe:
    Recommended dose: 5 micrograms per kilogram per day for subcutaneous injection.
    Myelosuppressive chemotherapy was administered no earlier than 24 hours after the first dose was administered. Do not give chemotherapy for the first 24 hours.

    [Storage]
    Recombinant human granulocyte colony-stimulating factor injection: sealed and preserved.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Fabry disease

    Alpha-galactosidase

    【Product name】Fabrazyme

    [English common name]Agalsidase alpha

    [Chinese common name]Alpha-galactosidase

    [English name]

    [Chinese other name]

    [indications]Fabry disease.

    【Dosage】As agarase beta (genetic recombination), 1 mg / kg body weight is usually administered intravenously every other week.

    [Storage] Store at 2-8 ° C and use within 24 hours.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.